New EASO guidance recommends semaglutide and tirzepatide as first-line treatments for obesity and its major complications Dr. Kamal Kant Kohli6 Oct 2025 8:30 AM ISTSemaglutide or tirzepatide should be the first line treatment for people living with obesity and most of its complications, according to a new...
Tirzepatide Improved Outcomes in Patients with Both Atrial Fibrillation and COPD: Study Jacinthlyn Sylvia4 Oct 2025 9:00 AM ISTA new study published in The American Journal of Medicine found tirzepatide, which is prescribed for diabetes and weight management, to significantly...
Tirzepatide proves to be more effective than semaglutide- Results of Surmount 5 Trial Deeksha Bhandari3 Oct 2025 12:09 PM ISTSURMOUNT-5 was a 72-week, Phase 3b, multicenter, randomized, open-label, comparator-controlled study that evaluated the efficacy and safety of...
Tirzepatide Improves Blood Sugar Control in Children With Type 2 Diabetes: SURPASS-PEDS Trial Dr. Kamal Kant Kohli20 Sept 2025 9:00 AM ISTNew research shows that that the diabetes/obesity medication tirzepatide can cause clinically meaningful improvements in blood sugar control and...
Tirzepatide and Thiazide Use in CKD Linked to Risk of Severe Hypercalcemia, Reveals Case Report Medha Baranwal16 Sept 2025 8:45 PM ISTUSA: Researchers have reported a potential risk of severe hypercalcemia when tirzepatide, a dual GIP and GLP-1 receptor agonist, is used in...
Tirzepatide- A novel therapeutic against metabolic dysfunction-associated steatotic liver disease, reports research Dr. Kamal Kant Kohli13 Sept 2025 9:15 AM ISTMetabolic dysfunction-associated steatohepatitis (MASLD) is a liver disease with complex pathogenesis, characterized by abnormal lipid accumulation...
EMA warns of sharp rise in illegal medicines sold in EU Ruchika Sharma8 Sept 2025 2:18 PM ISTEuropean Medicines Agency (EMA) and the Heads of Medicines Agencies (HMA) are warning the public about the growing threat of illegal medicines being...
Medical Bulletin 04/September/2025 Anshika Mishra4 Sept 2025 3:00 PM ISTHere are the top medical news for the day:Hepatitis B Vaccine May Lower Diabetes Risk: Study FindsA new study to be presented at the Annual Meeting of...
Weight Loss Drugs May Lower Risk of Heart Failure Hospitalization and Death by 40 Percent: Study Anshika Mishra4 Sept 2025 8:30 AM ISTA new large-scale study published in JAMA and presented at the European Society of Cardiology Congress reveals that glucagon-like peptide-1 (GLP-1)...
Tirzepatide superior to Semaglutide- SURMOUNT-5 Trial Results Deeksha Bhandari11 Aug 2025 12:54 PM IST In SURMOUNT-5 Treatment with tirzepatide MTD (10 or 15 mg) was superior to semaglutide MTD (1.7 or 2.4 mg) with respect to reduction in...
Indian pharma market registers 7.9 percent growth in July: Report MD Bureau9 Aug 2025 3:30 PM ISTNew Delhi: The Indian pharmaceutical market (IPM) registered a growth of 7.9 percent in July 2025, and cardiac and anti-diabetes therapy segments have...
Tirzepatide's Effectiveness in HFpEF linked to Baseline BMI and Fat Distribution: SUMMIT Trial Dr Riya Dave5 Aug 2025 9:00 AM ISTA post hoc analysis of the SUMMIT trial, published in JACC, reveals that baseline body mass index (BMI) and fat distribution significantly affect the...
